07:41 AM EDT, 04/12/2024 (MT Newswires) -- Novo Nordisk's ( NVO ) popular diabetes and weight-loss medicines Wegovy and Ozempic have no added risk of suicide, a European Medicines Agency risk assessment committee said Friday, disclosing results of an investigation of reports linking the drugs to suicidal thoughts.

The evidence does not support a causal link between the medicines and self-harm thoughts and actions, the EMA said.

Drugmakers of such treatments will continue to monitor the issue, according to the EMA.

Novo Nordisk ( NVO ) did not immediately respond to MT Newswires' request for comment.

Price: 126.45, Change: +1.05, Percent Change: +0.84